Max Robotics — Global Service Robot Directory + US Certification

About

Joris I. Erdmann is a leading surgeon-researcher in the field of minimally invasive hepato-pancreato-biliary (HPB) surgery, with a focus on the transition from laparoscopic to robotic approaches. His work critically examines the safety, feasibility, and economic implications of adopting robotic techniques for complex pancreatic and liver resections. Erdmann’s landmark study, “Impact of shifting from laparoscopic to robotic surgery during 600 minimally invasive pancreatic and liver resections” (39 citations), provides one of the largest single-center series assessing this paradigm shift, demonstrating that the transition is safe and feasible. He has further advanced the field through rigorous health-economic analyses, including a bottom-up cost comparison of robotic versus laparoscopic liver resection (7 citations) and a cost-analysis of implementing robot-assisted pancreatoduodenectomy (3 citations). His research also explores specialized applications, such as robotic hepatic arterial infusion pump placement for unresectable intrahepatic cholangiocarcinoma (6 citations). By combining clinical outcomes with cost-effectiveness data, Erdmann’s work provides essential evidence for centers worldwide considering the adoption of robotic HPB surgery, helping to shape both surgical practice and healthcare policy.